{"id":"W1805934449","doi":"10.1016/j.jacc.2010.11.015","title":"Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease","year":2011,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"ca_institutions":"Resverlogix (Canada)","funders":"Anthera; Amarin Corporation; Schering-Plough; Sanofi; Roche; GlaxoSmithKline; Novartis; Pfizer","keywords":"Medicine; Tolerability; Apolipoprotein B; Internal medicine; Placebo; Coronary artery disease; Statin; Endocrinology; Cholesterol; Atorvastatin; Lipoprotein; Clinical endpoint; Gastroenterology; Adverse effect; Cardiology; Pharmacology; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004818917,0.0004711593,0.001645235,0.0002375714,0.0003008595,0.0004973874,0.0002944842,0.0007190963,0.001605781],"category_scores_gemma":[0.001050338,0.0002721782,0.0006327427,0.0002202438,0.000440253,0.0004014223,0.000236039,0.001659769,0.0003138623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003893907,"about_ca_system_score_gemma":0.000476073,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005065961,"about_ca_topic_score_gemma":0.00112086,"domain_scores_codex":[0.9997945,0.00007564684,0.00002166025,0.00003528079,0.00002610971,0.00004677012],"domain_scores_gemma":[0.9996248,0.0001091126,0.00007482631,0.00003490269,0.00002391075,0.0001323201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7444962,0.01779056,0.01163678,0.0006951896,0.001201997,0.0004564555,0.0001563141,0.0006789214,0.05506594,0.0002842364,0.001274265,0.1662633],"study_design_scores_gemma":[0.439368,0.4336478,0.09215426,0.0001521886,0.00258652,0.0008440637,0.0002577494,0.00390375,0.02305491,0.0003412428,0.003597461,0.00009195106],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959347,0.002587495,0.0001802232,0.0002307227,0.0001038726,0.00006861165,0.00009110735,0.00004328988,0.0007599607],"genre_scores_gemma":[0.9981157,0.000789589,0.0002381088,0.0001593292,0.0001422589,0.00005827077,0.0001090053,0.000005864784,0.0003819146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001645235,"threshold_uncertainty_score":0.005371869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01731362290590923,"score_gpt":0.2373319743941632,"score_spread":0.220018351488254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}